Table 1.

Demographic and Clinical Characteristics (n=744)

Patient characteristics	n (%)
Age in years (mean ± SD)	60.5 ± 14.6
Female	307 (41.3%)
Race/Ethnicity
White non-Hispanic	182 (24.5%)
Black non-Hispanic	307 (41.3%)
Hispanic	255 (34.3%)
ICH Location
Lobar	207 (27.8%)
Non-Lobar
Deep (includes 11 primary IVH)	446 (59.9%)
Cerebellum	55 (7.4%)
Brainstem	36 (4.8%)
Admission GCS, mean ± SD	12.4 ± 3.7
median (IQR)	15 (11–15)
Hematoma Volume (cc), mean ± SD	20.64 ± 24.95
range	0–152.96
median (IQR)	11.46 (4.11–27.11)
Presence of Intraventricular Hemorrhage	337 (45.3%)
Craniotomy	56 (7.5%)
Warfarin during 2 weeks prior to onset of ICH	67 (9.0%)
AED prophylaxis during hospital stay	289 (38.8%)
AED medications, N (% of 289)
levetiracetam	248 (85.8%)
phenytoin/fosphenytoin	31 (10.7%)
levetiracetam & phenytoin	10 (3.5%)